Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 5;47(1):12.
doi: 10.1186/s40463-018-0257-z.

Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma

Affiliations

Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma

Yi-Chan Lee et al. J Otolaryngol Head Neck Surg. .

Abstract

Background: Sinonasal adenoid cystic carcinoma is a rare malignancy of the head and neck. Cavernous sinus invasion from sinonasal adenoid cystic carcinoma and its related management have rarely been investigated. This study evaluated the relationship between treatment outcome and cavernous sinus involvement in addition to other parameters.

Methods: A retrospective case series study was conducted at a tertiary referral center. The medical records of 47 patients diagnosed with primary sinonasal adenoid cystic carcinoma between 1984 and 2015 were retrospectively reviewed. The survival impact of the primary treatment modalities and the anatomic sites of tumor involvement were analyzed.

Results: Cavernous sinus invasion was observed in 8 patients (17%), of whom 7 had ACC tumors originating from the maxillary sinus. The results of univariate analysis revealed that tumor stage, primary surgery, and the absence of skull-base and infratemporal fossa invasion were associated with better overall survival (P = 0.033, P = 0.012, P = 0.011, and P = 0.040, respectively) and better disease-free survival (P = 0.019, P = 0.001, P = 0.017, and P = 0.029, respectively). Multivariate analysis identified primary surgery as the only independent prognostic factor for disease-free survival (P = 0.026). Cavernous sinus invasion by sinonasal adenoid cystic carcinoma was not associated with worse overall survival or disease-free survival (P = 0.200 and P = 0.198, respectively).

Conclusions: Because maxillary adenoid cystic carcinoma is associated with a higher rate of cavernous sinus invasion, such cases warrant caution during preoperative planning. Primary surgery as the initial therapy provides better locoregional control and survival for patients with sinonasal adenoid cystic carcinoma. Cavernous sinus invasion did not significantly impact survival; thus, it should not be regarded as a contraindication for curative treatment.

Keywords: Adenoid cystic carcinoma; Cavernous sinus; Chemoradiation; Head and neck; Sinonasal cancer; Surgery.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The retrospective review of medical records for this study was approved by the Institutional Review Board (201600713B0).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
a Kaplan-Meier curves of overall survival by tumor stage, primary surgery, skull base invasion, infratemporal fossa invasion and cavernous sinus invasion. b Kaplan-Meier curves of disease-free survival by tumor stage, primary surgery, skull base invasion, infratemporal fossa invasion and cavernous sinus invasion. CRT, chemoradiation therapy; RT, radiotherapy
Fig. 2
Fig. 2
a Kaplan-Meier curves of overall survival by postoperative adjuvant therapy and primary chemoradiation therapy compared with primary radiotherapy. b Kaplan-Meier curves of disease-free survival by postoperative adjuvant therapy and primary chemoradiation therapy compared with primary radiotherapy. CRT, chemoradiation therapy; RT, radiotherapy

Similar articles

Cited by

References

    1. Patel SH, Wang Z, Wong WW, Murad MH, Buckey CR, Mohammed K, et al. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol. 2014;15(9):1027–1038. doi: 10.1016/S1470-2045(14)70268-2. - DOI - PubMed
    1. Robin TP, Jones BL, Gordon OM, Phan A, Abbott D, McDermott JD, et al. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies. Cancer. 2017;123(16):3040–3049. doi: 10.1002/cncr.30686. - DOI - PMC - PubMed
    1. Lupinetti AD, Roberts DB, Williams MD, Kupferman ME, Rosenthal DI, Demonte F, et al. Sinonasal adenoid cystic carcinoma: the M. D. Anderson cancer center experience. Cancer. 2007;110(12):2726–2731. doi: 10.1002/cncr.23096. - DOI - PubMed
    1. Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer. 2001;92(12):3012–3029. doi: 10.1002/1097-0142(20011215)92:12<3012::AID-CNCR10131>3.0.CO;2-E. - DOI - PubMed
    1. Rhee CS, Won TB, Lee CH, Min YG, Sung MW, Kim KH, et al. Adenoid cystic carcinoma of the sinonasal tract: treatment results. Laryngoscope. 2006;116(6):982–986. doi: 10.1097/01.mlg.0000216900.03188.48. - DOI - PubMed

MeSH terms

LinkOut - more resources